Biofrontera Inc.
BFRI· Nasdaq
BFRIBiofrontera Inc.
Filed Nov 30, 2021 · 10-Q · 61 days after period end · 0001493152-21-030058
| Metric | Q3 2021 | Q3 2020 |
|---|---|---|
| Revenue | $4.33M | $3.25M |
| Net Income | -$16.01M | -$2.99M |
| EPS Diluted | -$2.00 | -$2,984.67 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Biofrontera Inc. · CIK 1858685 · Engraved from SEC EDGAR
ended Sep 30, 2021 · filed Nov 30, 2021 · 61 d after period end
